Tech Convergence, Quality Data Needed To Accelerate Korea’s AI-Powered R&D

Players Still ‘Fragmented And Segmented’

Bio Korea 2025
Korea Still Needs Relevant Legal Arrangements In AI Drug Development

More from South Korea

More from Conferences